Pasupathy, S.; Tavella, R.; Zeitz, C.; Edwards, S.; Worthley, M.; Arstall, M.; Beltrame, J.F.
Anti-Anginal Efficacy of Zibotentan in the Coronary Slow-Flow Phenomenon. J. Clin. Med. 2024, 13, 1337.
https://doi.org/10.3390/jcm13051337
AMA Style
Pasupathy S, Tavella R, Zeitz C, Edwards S, Worthley M, Arstall M, Beltrame JF.
Anti-Anginal Efficacy of Zibotentan in the Coronary Slow-Flow Phenomenon. Journal of Clinical Medicine. 2024; 13(5):1337.
https://doi.org/10.3390/jcm13051337
Chicago/Turabian Style
Pasupathy, Sivabaskari, Rosanna Tavella, Christopher Zeitz, Suzanne Edwards, Matthew Worthley, Margaret Arstall, and John F. Beltrame.
2024. "Anti-Anginal Efficacy of Zibotentan in the Coronary Slow-Flow Phenomenon" Journal of Clinical Medicine 13, no. 5: 1337.
https://doi.org/10.3390/jcm13051337
APA Style
Pasupathy, S., Tavella, R., Zeitz, C., Edwards, S., Worthley, M., Arstall, M., & Beltrame, J. F.
(2024). Anti-Anginal Efficacy of Zibotentan in the Coronary Slow-Flow Phenomenon. Journal of Clinical Medicine, 13(5), 1337.
https://doi.org/10.3390/jcm13051337
